United States:
FDA Reopens Comment Period On Homeopathic Product Regulation: Evaluating The Food And Drug Administration's Regulatory Framework After A Quarter-Century
24 September 2015
Jones Day
To print this article, all you need is to be registered or login on Mondaq.com.
In the September 9, 2015, Federal Register, FDA
announced it is reopening the comment period on "Homeopathic
Product Regulation: Evaluating the Food and Drug
Administration's Regulatory Framework After a
Quarter-Century" to allow interested persons additional time
to submit comments. Comments are now due November 9, 2015.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
